Published in Int J Hyg Environ Health on March 25, 2011
Systems Biology and Biomarkers of Early Effects for Occupational Exposure Limit Setting. J Occup Environ Hyg (2015) 0.87
Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCDD. Neurotoxicol Teratol (2015) 0.76
Development of screening tools for the interpretation of chemical biomonitoring data. J Toxicol (2012) 0.75
Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD. Environ Toxicol Pharmacol (2017) 0.75
Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture. Environ Health Perspect (2016) 0.75
Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol (2005) 1.26
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci (2013) 1.10
Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev (2014) 1.09
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals. Environ Health Perspect (2012) 1.04
Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy. J Expo Sci Environ Epidemiol (2008) 0.99
Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels. J Expo Anal Environ Epidemiol (2002) 0.96
Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004. J Expo Sci Environ Epidemiol (2009) 0.94
Human biomonitoring assessment values: approaches and data requirements. Int J Hyg Environ Health (2011) 0.92
Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol (2008) 0.91
Interpreting variability in population biomonitoring data: role of elimination kinetics. J Expo Sci Environ Epidemiol (2012) 0.90
Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP). Regul Toxicol Pharmacol (2009) 0.89
Biomonitoring Equivalents for bisphenol A (BPA). Regul Toxicol Pharmacol (2010) 0.87
Perspective on serum dioxin levels in the United States: an evaluation of the NHANES data. J Expo Sci Environ Epidemiol (2008) 0.86
Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions. Regul Toxicol Pharmacol (2010) 0.86
Consideration of dosimetry in evaluation of ToxCast™ data. J Appl Toxicol (2011) 0.85
A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol (2013) 0.85
A mechanism-based cancer risk assessment for 1,4-dichlorobenzene. Regul Toxicol Pharmacol (2007) 0.84
Urinary DEHP metabolites and fasting time in NHANES. J Expo Sci Environ Epidemiol (2011) 0.82
Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7). Regul Toxicol Pharmacol (2009) 0.82
Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme. Regul Toxicol Pharmacol (2010) 0.82
Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere (2012) 0.81
Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). Regul Toxicol Pharmacol (2008) 0.81
Is age an independent risk factor for chemically induced acute myelogenous leukemia in children? J Toxicol Environ Health B Crit Rev (2007) 0.80
Biomonitoring Equivalents for triclosan. Regul Toxicol Pharmacol (2010) 0.80
Biomonitoring equivalents for DDT/DDE. Regul Toxicol Pharmacol (2011) 0.80
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99). Regul Toxicol Pharmacol (2011) 0.79
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria. J Expo Sci Environ Epidemiol (2011) 0.79
Biomonitoring equivalents for hexachlorobenzene. Regul Toxicol Pharmacol (2010) 0.79
Biomonitoring Equivalents (BE) dossier for trihalomethanes. Regul Toxicol Pharmacol (2008) 0.78
Biomonitoring equivalents for deltamethrin. Regul Toxicol Pharmacol (2011) 0.78
Biomonitoring Equivalents (BE) dossier for toluene (CAS No. 108-88-3). Regul Toxicol Pharmacol (2008) 0.77
Derivation of biomonitoring equivalent (BE) values for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds: a screening tool for interpretation of biomonitoring data in a risk assessment context. J Toxicol Environ Health A (2008) 0.77
Assessment of margin of exposure based on biomarkers in blood: an exploratory analysis. Regul Toxicol Pharmacol (2011) 0.77
Biomonitoring data for 2,4-dichlorophenoxyacetic acid in the United States and Canada: interpretation in a public health risk assessment context using Biomonitoring Equivalents. Environ Health Perspect (2010) 0.77
TCDD exposure estimation for workers at a New Zealand 2,4,5-T manufacturing facility based on serum sampling data. J Expo Sci Environ Epidemiol (2009) 0.75
Development of screening tools for the interpretation of chemical biomonitoring data. J Toxicol (2012) 0.75
Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens. Birth Defects Res B Dev Reprod Toxicol (2014) 0.75
Do children have increased susceptibility for developing secondary acute myelogenous leukemia? Chem Biol Interact (2005) 0.75
United States Voluntary Children's Chemical Evaluation Program (VCCEP) risk assessment for children exposed to benzene. Toxicol Mech Methods (2011) 0.75
Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH. Int J Hyg Environ Health (2011) 0.75